MATTHEW FOY

PARTNER, SR ONE
Pharma
Ato Bio
Israel

Business Expert Clinical Sciences
Biography

Mr. Foy joined SR One’s London office in 2011. Previously he was a Vice President at Greenhill & Co, an M&A Investment Bank and Private Equity firm in New York. Matthew studied Molecular Biology at The University of Oxford; Drug Discovery at UCL; Corporate Finance at The London Business School and holds various FSA & SEC qualifications. His portfolio companies include AtoxBio, Progenitor, PsiOxus, Pulmocide, Puridify and VHSquared.

Research Intrest

Healthcare

Global Scientific Words in Clinical Sciences